Melissa Suran

2 months ago | jamanetwork.com | Devin K. Schweppe |Brian J. Beliveau |Andrew N Hoofnagle |Melissa Suran

Molecular Phenotyping With Proteomics Medical News & Perspectives After the Genome—A Brief History of Proteomics Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular Events Hannes Helgason, PhD; Thjodbjorg Eiriksdottir, MSc; Magnus O. Ulfarsson, PhD; Abhishek Choudhary, PhD; Sigrun H. Lund, PhD; Erna V. Ivarsdottir, PhD; Grimur Hjorleifsson Eldjarn, PhD; Gudmundur Einarsson, PhD; Egil Ferkingstad, PhD; Kristjan H. S.

Jan 17, 2025 | jamanetwork.com | Samantha Anderer |Melissa Suran

Greater exposure to long-term air pollution may be associated with a higher risk of blood clots that can develop in deep veins, a longitudinal analysis of participants in the Multi-Ethnic Study of Atherosclerosis has found. The article, published in Blood, followed up about 6600 adults in and around 6 different US metropolitan areas for roughly 17 years, during which time 248 cases of venous thromboembolism occurred.

Feb 28, 2024 | jamanetwork.com | Melissa Suran

Despite its elimination in the US in 2000, measles cases are being reported across the country. As of February 22, 35 cases have been reported this year in Arizona, California, Florida, Georgia, Indiana, Louisiana, Maryland, Minnesota, Missouri, New Jersey, New York City, Ohio, Pennsylvania, Virginia, and Washington, according to the US Centers for Disease Control and Prevention (CDC).

Feb 21, 2024 | jamanetwork.com | Melissa Suran

Following an investigation announced this past November, the US Food and Drug Administration (FDA) recently said it will now require boxed warnings—the highest safety-related caution for medications—for all chimeric antigen receptor (CAR) T-cell therapies. According to the agency, these blood cancer treatments may pose a risk of secondary cancers. In CAR T-cell therapy, patients’ T cells (small round) are modified to target antigens on cancer cells.

Jan 31, 2024 | jamanetwork.com | Melissa Suran

After decades of being outlawed across the globe, psychedelic drugs are returning to the psychiatric and neuroscience research scene. Although some of these mind-altering substances may be promising psychotherapeutics for issues including anxiety and depression, many unknowns remain, and they’re still mostly illegal recreationally. Nevertheless, nonmedical use is on the rise.